AIM: To describe drugs used in the chemotherapy of testis and penis neoplasms.
MATERIAL: Bibliographical search was performed from the database Medline (National Library of Medicine, PubMed) and websites of the HAS and the ANSM. The search was focused on the characteristics, the mode of action, the efficiency and the side effects of the various drugs concerned.
RESULTS: Nowadays, the chemotherapy is perfectly codified in adjuvant treatment or in first-line treatment of metastatic testis cancer. A single dose of carboplatin for seminoma testicular (stade I) in adjuvant treatment situation is one of the latest advances. Concerning penis cancer, the optimal protocols validated by a high level of evidence are missing.
CONCLUSION: The chemotherapy in testis and penis neoplasms knew few advances in recent years. So, it is necessary to include patients in clinical research protocols.
Written by:
Deville JL, Flechon A, Bruyère F, Karsenty G, Guy L, Bastide C. Are you the author?
Service d'oncologie, hôpital de la Timone, Aix-Marseille université, AP-HM, 13385 Marseille cedex 5, France.
Reference: Prog Urol. 2013 Nov;23(15):1265-70.
doi: 10.1016/j.purol.2013.08.321
PubMed Abstract
PMID: 24183085
Article in French.
UroToday.com Testicular Cancer Section
